FINHUB Insights

Language: EN
Sign in Sign up

All companies, by profit

505 companies and 2079 sets of results: the S&P 500, and sometimes a company from outside it. We can draw the statement for 418.

505 of 505
# Company Market cap Share price Net profit Quarter
326 LITE S&P 500 Lumentum Rank 326 S&P 500 Share price: $835.03 −9.9% Q4 FY26 LITE Lumentum $74.9B $835.03 −9.9% −$6.9B Last four quarters 2026: Q1, Q2, Q3, Q4 Q4 FY26 LITE Lumentum
327 INTC S&P 500 Intel Rank 327 S&P 500 Share price: $97.19 −5.6% Q2 FY26 INTC Intel $490B $97.19 −5.6% −$11.3B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 Q2 FY26 INTC Intel
328 MSTR outside the index Strategy Rank 328 outside the index Share price: $136.94 +4.6% Q2 FY26 MSTR Strategy $52.6B $136.94 +4.6% −$30.4B Last four quarters 2026: Q1, Q2 · 2025: Q3, Q4 Q2 FY26 MSTR Strategy
Not ranked below this line: we do not hold four quarters in a row, or a quarter's bottom line is withheld because the filing's copy of it cannot be trusted, so the figure is not the same quantity as the ones above it.
– MRK S&P 500 Merck & Co. S&P 500 Share price: $144.85 +0.6% Q3 FY25 MRK Merck & Co. $357B $144.85 +0.6% $15.3B 3 of four quarters in a row 2025: Q1, Q2, Q3 Q3 FY25 MRK Merck & Co.
– JNJ S&P 500 Johnson & Johnson S&P 500 Share price: $266.32 +0.3% Q2 FY26 JNJ Johnson & Johnson $642B $266.32 +0.3% $10.8B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 JNJ Johnson & Johnson
– CVS S&P 500 CVS Health S&P 500 Share price: $95.55 +0.9% Q2 FY26 CVS CVS Health $122B $95.55 +0.9% $8.9B 3 of four quarters in a row 2026: Q1, Q2 · 2025: Q4 Q2 FY26 CVS CVS Health
– ECHO S&P 500 EchoStar S&P 500 Share price: $93.89 +0.8% Q2 FY26 ECHO EchoStar $27.3B $93.89 +0.8% $8.3B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 ECHO EchoStar
– COF S&P 500 Capital One S&P 500 Share price: $206.68 −0.8% Q1 FY26 COF Capital One $127B $206.68 −0.8% $7.5B 3 of four quarters in a row 2026: Q1 · 2025: Q3, Q4 Q1 FY26 COF Capital One
– BMY S&P 500 Bristol Myers Squibb S&P 500 Share price: $64.10 +0.7% Q2 FY26 BMY Bristol Myers Squibb $131B $64.10 +0.7% $6.0B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 BMY Bristol Myers Squibb
– CMCSA S&P 500 Comcast S&P 500 Share price: $24.88 −1.3% Q2 FY26 CMCSA Comcast $88.3B $24.88 −1.3% $5.7B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 CMCSA Comcast
– GEV S&P 500 GE Vernova S&P 500 Share price: $874.76 −8.6% Q2 FY26 GEV GE Vernova $233B $874.76 −8.6% $5.4B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 GEV GE Vernova
– GM S&P 500 General Motors S&P 500 Share price: $87.16 +1.8% Q2 FY26 GM General Motors $76.5B $87.16 +1.8% $3.9B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 GM General Motors
– KLAC S&P 500 KLA S&P 500 Share price: $169.09 −6.4% Q3 FY26 KLAC KLA $221B $169.09 −6.4% $3.5B 3 of four quarters in a row 2026: Q1, Q2, Q3 Q3 FY26 KLAC KLA
– IBM S&P 500 IBM S&P 500 Share price: $249.09 +2.4% Q2 FY26 IBM IBM $235B $249.09 +2.4% $3.4B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 IBM IBM
– TJX S&P 500 TJX Companies S&P 500 Share price: $125.99 +0.0% Q2 FY27 TJX TJX Companies $139B $125.99 +0.0% $2.9B 2 of four quarters in a row 2027: Q1, Q2 Q2 FY27 TJX TJX Companies
– DUK S&P 500 Duke Energy S&P 500 Share price: $119.02 −0.3% Q1 FY26 DUK Duke Energy $92.8B $119.02 −0.3% $2.7B 2 of four quarters in a row 2026: Q1 · 2025: Q4 Q1 FY26 DUK Duke Energy
– PFE S&P 500 Pfizer S&P 500 Share price: $27.72 +0.0% Q1 FY26 PFE Pfizer $158B $27.72 +0.0% $2.7B 1 of four quarters in a row 2026: Q1 Q1 FY26 PFE Pfizer
– CNC S&P 500 Centene S&P 500 Share price: $69.41 +4.5% Q2 FY26 CNC Centene $34.3B $69.41 +4.5% $2.6B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 CNC Centene
– F S&P 500 Ford Motor S&P 500 Share price: $13.86 −0.8% Q1 FY26 F Ford Motor $55.3B $13.86 −0.8% $2.6B 1 of four quarters in a row 2026: Q1 Q1 FY26 F Ford Motor
– NEE S&P 500 NextEra Energy S&P 500 Share price: $81.63 −0.8% Q3 FY25 NEE NextEra Energy $170B $81.63 −0.8% $2.4B 1 of four quarters in a row 2025: Q3 Q3 FY25 NEE NextEra Energy
– MRSH S&P 500 Marsh McLennan S&P 500 Share price: $180.43 +2.0% Q2 FY26 MRSH Marsh McLennan $86.1B $180.43 +2.0% $2.4B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 MRSH Marsh McLennan
– DHI S&P 500 D. R. Horton S&P 500 Share price: $139.41 +1.1% Q3 FY26 DHI D. R. Horton $39.0B $139.41 +1.1% $2.1B 3 of four quarters in a row 2026: Q1, Q2, Q3 Q3 FY26 DHI D. R. Horton
– KHC S&P 500 Kraft Heinz S&P 500 Share price: $24.60 +0.0% Q1 FY26 KHC Kraft Heinz $29.2B $24.60 +0.0% not requoted $2.1B 3 of four quarters in a row 2026: Q1 · 2025: Q3, Q4 Q1 FY26 KHC Kraft Heinz
– NKE S&P 500 Nike S&P 500 Share price: $37.05 +0.7% Q3 FY26 NKE Nike $55.0B $37.05 +0.7% $2.0B 3 of four quarters in a row 2026: Q1, Q2, Q3 Q3 FY26 NKE Nike
– FANG S&P 500 Diamondback Energy S&P 500 Share price: $205.72 +0.4% Q2 FY26 FANG Diamondback Energy $57.6B $205.72 +0.4% $1.9B 2 of four quarters in a row 2026: Q1, Q2 Q2 FY26 FANG Diamondback Energy

The metric column switches between revenue, profit, margin and year-over-year growth, and every column on show can sort. A narrow screen moves the rank, the share price and the quarter under the company's name to keep the figures readable.

Revenue, profit and margin are the sum of the last four reported quarters, so companies with different fiscal years stay comparable. The mark next to each number says which quarters went into it; ⚠ means we do not hold four of them yet. Share price and market cap as of Sep 14, 2026 16:04 ET, the last quote taken; market cap is the price times the share count from the cover page of the latest filing. 2 companies we could not requote are as old as Aug 4, 2026 16:00 ET.